Skip to Main Content

Paper Details

SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients.
Front Immunol
1
2022
B and T cell, B cell, CD11c, CD4, CD4 T cell, COVID, COVID-19, IgG1, Omicron, Omicron-specific memory B cells, PAD, PAD syndromes, Primary antibody deficiency (PAD) syndromes, SARS-CoV, SARS-CoV-2, hypogammaglobulinemia, immunocompromised, immunodeficient, mRNA, memory B, memory B and T cells, memory B cell, patients, primary antibody deficiency, primary immunodeficiency disorders
Author NameAffiliation
Laura A VanBlarganWashington University School of Medicine
Rita E ChenWashington University School of Medicine
Rita E ChenWashington University School of Medicine
Michael S DiamondWashington University School of Medicine
Michael S DiamondWashington University School of Medicine
Michael S DiamondCenter for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine
Michael S DiamondThe Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs, Washington University School of Medicine
Michael S DiamondWashington University School of Medicine
  • 1 - 8

Datasets

Release 1.2